SCHEMBL10128619

SCHEMBL10128619

Cc1ccc(N(c2ccccc2)c2c3ccccc3c(-c3ccc(-c4c5ccccc5c(N(c5ccccc5)c5ccc(C)cc5)c5ccccc45)cc3)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.41
CYP2C19 P33261 2/20 0.37
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ADORA2A P29274 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12721991 0.97 ACHE (0.43) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL12721978 0.97 ACHE (0.41) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL13222621 0.96 ACHE (0.44) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL13020013 0.95 ACHE (0.42) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL14577020 0.92 ACHE (0.41) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL7218845 0.91 CYP2C19 (0.40) ACHECYP2C19ALDH1A1L3MBTL1KDM4E
SCHEMBL11954097 0.91 ACHE (0.45) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL12619868 0.91 ACHE (0.45) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL10063931 0.91 ACHE (0.45) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL13807870 0.90 APP (0.43) ACHECYP2C19ALDH1A1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210104680-A1 ORGANIC ELECTROLUMINESCENT ELEMINT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-04-08 US disclosed
US-10910565-B2 Organic electroluminescent element, material for organic electroluminescent elements, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2021-02-02 US disclosed
US-10243145-B2 Organic electroluminescence device and organic light emitting medium IDEMITSU KOSAN CO., LTD. (JP) 2019-03-26 US disclosed
US-20180212152-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC LIGHT EMITTING MEDIUM IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180212152-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC LIGHT EMITTING MEDIUM IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-9960358-B2 Organic electroluminescence device and organic light emitting medium IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 US disclosed
US-9960358-B2 Organic electroluminescence device and organic light emitting medium IDEMITSU KOSAN CO., LTD. (JP) 2018-05-01 US disclosed
US-20170301863-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC LIGHT EMITTING MEDIUM IDEMITSU KOSAN CO., LTD. (JP) 2017-10-19 US disclosed
US-20170301863-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC LIGHT EMITTING MEDIUM IDEMITSU KOSAN CO., LTD. (JP) 2017-10-19 US disclosed
US-9728727-B2 Organic electroluminescence device and organic light emitting medium IDEMITSU KOSAN CO., LTD. (JP) 2017-08-08 US disclosed
US-20080001123-A1 Luminescent Ink Composition for Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD (JP) 2008-01-03 US disclosed
US-20080001123-A1 Luminescent Ink Composition for Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD (JP) 2008-01-03 US disclosed
US-20070237984-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC LIGHT EMITTING MEDIUM IDEMITSU KOSAN CO., LTD. (JP) 2007-10-11 US disclosed
US-20070237984-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC LIGHT EMITTING MEDIUM IDEMITSU KOSAN CO., LTD. (JP) 2007-10-11 US disclosed
US-20070207343-A1 Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD. (JP) 2007-09-06 US disclosed
US-20070207343-A1 Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD. (JP) 2007-09-06 US disclosed
US-20070200123-A1 Organic Electroluminescence Display Device IDEMITSU KOSAN CO., LTD. (JP) 2007-08-30 US disclosed
US-20070200123-A1 Organic Electroluminescence Display Device IDEMITSU KOSAN CO., LTD. (JP) 2007-08-30 US disclosed
US-20070170843-A1 Organic electroluminescent device and organic electroluminescent display IDEMITSU KOSAN CO., LTD. (JP) 2007-07-26 US disclosed
US-20070170843-A1 Organic electroluminescent device and organic electroluminescent display IDEMITSU KOSAN CO., LTD. (JP) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10243145-B2 Organic electroluminescence device and organic light emitting medium TRPA1, EPM2A, KCNN2 ACHE 682/4885CYP2C19 713/4885ALDH1A1 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.